The use of arm vein in lower-extremity revascularization: Results of 520 procedures performed in eight years

Abstract

Autogenous arm vein has been used successfully in a wide variety of lower-extremity revascularization procedures and has achieved excellent long- and short-term patency and limb salvage rates, higher than those generally reported for prosthetic or cryopreserved grafts. Its durability and easy accessibility make it an alternative conduit of choice when an adequate saphenous vein is not available.

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy

“…15 AFS and OS rates in BASIL are also similar to those reported by others around the same period. 68,69 So it would seem that the BSX outcomes reported in BASIL are representative of what can reasonably be achieved in this type of patient across the health economies of most developed countries. However, we accept that physicians in certain centers of excellence may believe that their own results are substantially better than those usually reported from multicenter and registry studies.…”

Femoro-Distal Bypass with Varicose Veins Covered by Prosthetic Mesh

“…Nevertheless, autologous saphenous vein is still the treatment of choice due to its long-term patency and resistance to infections [1][2][3][4][5]. Furthermore, Recommendation 40 of the TASC II states that the great saphenous vein (GSV) is a better conduit in which to perform femoro-distal bypass.…”

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia

“…3,4 The use of a prosthetic graft to an infrageniculate artery is associated with poor limb salvage and patency rates and a high risk of infection because of the presence of ulceration or gangrene. 5 In such circumstances, alternative autologous conduits had been proposed, such as an arm vein, 6 lesser saphenous vein, 7 or composite conduit. 8 In addition, various allogeneic materials, such as cryopreserved venous 9 and arterial 10 allografts, had been evaluated.…”